|
Themes | Subthemes |
|
(1) Disagreement with motive for discontinuation | Critical of authorities for discontinuing effective drug | Anticipate persistence of addiction problems | Feel irrationally deprived of pain medication | Address one issue by creating another | Blame prescribers for misuse and abuse | Question GPs ability to prescribe opioids | Discontinuation considered addicts not patients | Alternate solutions to addiction issues |
(2) Discontinuation negatively impacted pain control | Optimal pain relief with OxyContin | Poorer pain management with substitutes | Endure trials of alternate medications | Experience withdrawal symptoms | Increased pain affecting cognition and function | Retrain self to manage new medications | Cost barrier to OxyNEO | |
(3) Discontinuation insignificantly impacted pain control | Rate pain relief equivalent to before discontinuation | Continued receiving satisfactory pain control | Continued receiving inadequate pain control | Identification of differences in medications | Discontinuation has impact on other aspects | | | |
(4) Choosing to get off OxyContin permanently | Fear lifelong dependence on OxyContin | Addiction to OxyContin driving decision | Tolerate withdrawal symptoms | Bear worsened pain | Reliance on distraction to ease pain | | | |
(5) Learning to live with pain | Accepting life with pain | Recognize few alternatives | Wishing for a miracle drug | Hope to regain OxyContin | | | | |
(6) Barriers and opportunities in optimizing care | Learning about discontinuation from the media | Communication gap between patients and professionals | Feeling unheard by healthcare providers | Professionals not advising of addictive properties | Professionals not educating patients | Inadequate integration of general and pain clinics | Lack regulatory program to reassess pain | Not involving patients with decision-making |
|